Form 4 Tracker
IONIS PHARMACEUTICALS INC
IONS

78 insider filings · Latest: Jul 30, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Aug 4, 2025Aug 4 8:02 PMSchneider Eugene
Proposed Sale
9,549$42.88$409.5K

View →

Jul 30, 2025Jul 30 8:53 PMMonia Brett P
Proposed Sale
2,432$45.00$109.4K

View →

Apr 16, 2025Apr 16 9:41 PMJenne Kyle
Proposed Sale
3,016$28.36$85.5K

View →

Apr 16, 2025Apr 16 9:40 PMBirchler Brian
Proposed Sale
680$28.37$19.3K

View →

Apr 16, 2025Apr 16 9:38 PMBaroldi Joseph
Proposed Sale
3,928$28.40$111.6K

View →

Mar 11, 2025Mar 11 8:04 PMMonia Brett P
Proposed Sale
140$32.32$4.5K

View →

Feb 4, 2025Feb 4 10:15 PMO'NEIL PATRICK R.
Proposed Sale
7,372$32.13$236.9K

View →

Feb 4, 2025Feb 4 9:56 PMMonia Brett P
Proposed Sale
40,003$32.13$1.3M

View →

Feb 4, 2025Feb 4 9:45 PMO'NEIL PATRICK R.
Proposed Sale
7,372$32.13$236.9K

View →

Jan 31, 2025Jan 31 10:43 PMSchneider Eugene
Proposed Sale
1,700$33.00$56.1K

View →

Jan 31, 2025Jan 31 10:41 PMGeary Richard S
Proposed Sale
1,910$35.00$66.8K

View →

Jan 31, 2025Jan 31 10:03 PMSwayze Eric
Proposed Sale
1,857$35.00$65.0K

View →

Jan 31, 2025Jan 31 10:02 PMO'NEIL PATRICK R.
Proposed Sale
1,910$35.00$66.8K

View →

Jan 31, 2025Jan 31 10:01 PMHOUGEN ELIZABETH L
Proposed Sale
2,069$35.00$72.4K

View →

Jan 31, 2025Jan 31 9:59 PMBENNETT C FRANK
Proposed Sale
1,803$35.00$63.1K

View →

Jan 31, 2025Jan 31 9:58 PMMonia Brett P
Proposed Sale
13,242$33.53$444.0K

View →

Jan 16, 2025Jan 17 12:31 AMSwayze Eric
Proposed Sale
7,154$32.70$233.9K

View →

Jan 16, 2025Jan 17 12:30 AMSchneider Eugene
Proposed Sale
6,523$32.70$213.3K

View →

Jan 16, 2025Jan 17 12:29 AMO'NEIL PATRICK R.
Proposed Sale
7,360$32.70$240.7K

View →

Jan 16, 2025Jan 17 12:28 AMMonia Brett P
Proposed Sale
33,445$32.70$1.1M

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 3, 2026Mar 5 11:14 PMShannon L. DeversEVP, Chief Human Resources Ofc
Option Exercise
20,106$52.878,877(D)

View →

Mar 3, 2026Mar 5 11:13 PMBENNETT C FRANKEVP, Chief Scientific Officer
Option Exercise
65,089$60.890(D)

View →

Mar 4, 2026Mar 5 11:13 PMJoseph BaroldiEVP, Chief Business Officer
Option Exercise
439$56.783,866(I)

View →

Mar 3, 2026Mar 5 11:13 PMJoseph BaroldiEVP, Chief Business Officer
Option Exercise
1,699$56.784,104(I)

View →

Feb 2, 2026Feb 4 9:06 PMBENNETT C FRANKEVP, Chief Scientific Officer
Option Exercise
65,089$60.890(D)

View →

Jan 15, 2026Jan 21 1:21 AMMichael J. YangDirector
Option Exercise
1,9307,150(D)

View →

Jan 15, 2026Jan 21 1:21 AMEric SwayzeEVP Research
Option Exercise
21,477386(I)

View →

Jan 15, 2026Jan 21 1:21 AMEric SwayzeEVP Research
Grant/Award
35,700$0.00611(I)

View →

Jan 15, 2026Jan 21 1:21 AMEugene SchneiderEVP, Chf Clinical Develop Ofcr
Option Exercise
21,68539,251(D)

View →

Jan 15, 2026Jan 21 1:21 AMEugene SchneiderEVP, Chf Clinical Develop Ofcr
Grant/Award
35,475$0.0048,926(D)

View →

Jan 15, 2026Jan 21 1:20 AMPatrick R. O'NeilEVP CLO & General Counsel
Option Exercise
21,47339,251(D)

View →

Jan 15, 2026Jan 21 1:20 AMPatrick R. O'NeilEVP CLO & General Counsel
Grant/Award
35,475$0.0048,926(D)

View →

Jan 15, 2026Jan 21 1:20 AMBrett P MoniaDirector, Chief Executive Officer
Grant/Award
156,585$0.00205,719(D)

View →

Jan 15, 2026Jan 21 1:20 AMBrett P MoniaDirector, Chief Executive Officer
Option Exercise
89,145163,014(D)

View →

Jan 2, 2026Jan 21 1:20 AMHolly B. KordasiewiczEVP, Chief Development Officer
Grant/Award
7,500$79.6716,600(D)

View →

Jan 15, 2026Jan 21 1:18 AMHolly B. KordasiewiczEVP, Chief Development Officer
Option Exercise
11,11920,830(D)

View →

Jan 15, 2026Jan 21 1:18 AMHolly B. KordasiewiczEVP, Chief Development Officer
Grant/Award
24,90045,730(D)

View →

Jan 15, 2026Jan 21 1:18 AMKyle JenneEVP, Chf GL Pdt Str Ofcr
Option Exercise
7,01329,664(D)

View →

Jan 15, 2026Jan 21 1:18 AMKyle JenneEVP, Chf GL Pdt Str Ofcr
Grant/Award
35,475$0.0037,725(D)

View →

Jan 15, 2026Jan 21 1:18 AMHOUGEN ELIZABETH LEVP, Finance & CFO
Option Exercise
28,72955,940(D)

View →